This proficiency test material includes a range of veterinary drugs within bovine liver.
Animal products for human consumption are tightly legislated and closely monitored for compliance. Veterinary medicines used in animals are likely to have a pharmacological effect in humans. Hence, for many veterinary medicines, there are extremely low maximum residue limits or even no MRL (i.e. any detection is non-compliant). The Fapas quality control materials are produced in keeping with EU MRLs or minimum required performance limit (MRPL) where MRLs are not set. The result reporting requirements are also in keeping with quality control guidelines laid out in EC/657/2002. Fapas veterinary medicine quality control materials include incurred residues, as well as fortified animal products, and are suitable for all methods, including screening methods (for the detection of the total amount of that chemical class).
The ability to achieve large amounts of high-quality livestock to satisfy global demand is important to ensure large financial rewards are safeguarded for producers. This can lead to poor farming practices being utilised to ensure financial rewards are met, which can increase the risk of high levels of veterinary medicine residues being passed on to the end consumer, which can prove harmful to health in some instances.
As such it is imperative to highlight any high levels of veterinary medicine residues quickly and accurately. To maintain this ability extensive quality assurance programmes should be undertaken, utilising Fapas proficiency tests to inform and evaluate your current testing ability, with ongoing quality control materials ensuring your testing ability is maintained across a range of testing environments throughout the year.
Through real food matrices, Fapas quality control materials are immediately comparable to your routine analysis, this can allow you to highlight and act on potential disparities within your ongoing test results.